SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052219
Filing Date
2020-11-09
Accepted
2020-11-09 08:06:31
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-10q_20200930.htm   iXBRL 10-Q 2642057
2 EX-31.1 allk-ex311_8.htm EX-31.1 20374
3 EX-31.2 allk-ex312_9.htm EX-31.2 20231
4 EX-32.1 allk-ex321_6.htm EX-32.1 9708
5 EX-32.2 allk-ex322_7.htm EX-32.2 9714
  Complete submission text file 0001564590-20-052219.txt   8478922

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA allk-20200930.xsd EX-101.SCH 42110
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE allk-20200930_cal.xml EX-101.CAL 44361
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allk-20200930_def.xml EX-101.DEF 132552
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20200930_lab.xml EX-101.LAB 369160
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20200930_pre.xml EX-101.PRE 277933
11 EXTRACTED XBRL INSTANCE DOCUMENT allk-10q_20200930_htm.xml XML 1706744
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 201296193
SIC: 2834 Pharmaceutical Preparations